Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1

1. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002768

2. Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments

   Qamar Abuhassan, Ali M Atoom, M.M. Rekha +5

   МақолаPsoriasis: Treatment and PathogenesisHuman Immunology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.004934

3. Hypoxia‐Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies

   Qamar Abuhassan, Hamzeh J. Al‐Ameer, Hani Moslem Ahmed +4

   МақолаCancer, Hypoxia, and MetabolismIUBMB Life20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.013100